Company attributes
Other attributes
Sugarlogix was found in 2016 and manufactures complex sugars found within human breast milk that have probiotic functions using biologically engineered yeast. The complex sugars made by Sugarlogix are made to selectively feed bacteria found within the human gut biome that help restore ratios of bacteria within the gut that promote better health.
Co-founder and CSO of Sugarlogix Kulika Chomvong explains the technology and purpose behind Sugarlogix.
On May 3, 2017 concluded a seed funding round and raised an undisclosed sum of money from Indie Bio and SOSV.
The first product Sugarlogix is commercializing is 2-Fucosyllactose (2-FL), a prebiotic protein that is found only in human breast milk. The company secured FDA approval for their 2-FL, and have plans to begin shipping in 2018.
